As of April 18, 2025, PMV Pharmaceuticals (PMVP) has a market cap of $52.972 million USD. According to our data, PMV Pharmaceuticals is ranked No.8039 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $52.97 M |
-32.21%
|
Dec 31, 2024 | $78.14 M |
-51.29%
|
Dec 29, 2023 | $0.16 B |
-64.37%
|
Dec 30, 2022 | $0.45 B |
-62.34%
|
Dec 31, 2021 | $1.20 B |
-62.45%
|
Dec 31, 2020 | $3.18 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.27 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$9.97 B |
-0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.41 B |
0.000 M
|
![]() USA
|
Market Cap | = | PMVP Stock Price | * | PMVP Shares Outstanding |
= | $1.02 | * | 51.93 M | |
= | $52.97 M |